PlainPharmaWatch

CMS Open Payments · Program Year 2024

Vericel Corporation

Vericel Corporation reported $1,342,981.04 in payments to 3,314 physicians and teaching hospitals across 3,339 transactions.

See the rankings → How this is sourced
$1.3M
Total payments
3,339
Transactions
3,314
Recipients
+$444.3K
General Payments vs PY2023

Vericel Corporation reported $1,342,981.04 in payments to 3,314 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #548 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $405.24 per recipient across 8 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Vericel Corporation pairs above-median payment volume with an unusually diversified payment pattern across a wide recipient base.

#548
of 1,925 companies
0.0%
of all US industry payments
0.1%
paid to its single top recipient
8
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Vericel Corporation's CMS-reported General Payments increased by $444.3K (+53.9%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: VERICEL CORPORATIONPY2023: VERICEL CORPORATIONPY2024: Vericel Corporation. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$824.7KPY2024$1.3M
PY2023
$824,731.69
PY2024
$1,269,076.30

How Vericel Corporation ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Vericel Corporation's total vs. every reporting company

CMS Open Payments, Program Year 2024

$1,342,981 Top 28% higher than 72% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). This entry sits in this band. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Vericel Corporation

Rank #548 of 1,925 companies in CMS Open Payments for 2024 belongs to Vericel Corporation, which reported $1,342,981.04 across 3,339 transactions to 3,314 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $402.21 per transaction and $405.24 per recipient.

The 8-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $530.3K, accounting for 39.5% of the company's reported total and 151 transactions.

General Payment Breakdown by Type

Vericel Corporation made 8 types of general payments. "Consulting Fee" is the largest category at $530.3K, 39.5% of the company's reported total.

How Vericel Corporation divides its payments

Top payment categories by total reported dollar volume

1. Consulting Fee$530.3K2. Honoraria$455.6K3. Food and Beverage$120.0K4. Travel and Lodging$92.4K5. Grant$55.5K6. Charitable Contribution$12.5K7. Compensation for Services…$2.4K8. Education$327.90
Payment Type Amount Transactions
Consulting Fee $530.3K 151
Honoraria $455.6K 188
Food and Beverage $120.0K 2,683
Travel and Lodging $92.4K 243
Grant $55.5K 5
Charitable Contribution $12.5K 4
Compensation for Services Other Than Consulting $2.4K 18
Education $327.90 22

Recipient Concentration in General Payments

The five largest recipient relationships account for $294,296.12 (23.2%) of $1,269,076.30 in this company's General Payments records across 1,761 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Vericel Corporation

The five named recipients with the highest reported General Payments from this company

Matthew a Tao$68.3KMichael Kuhn$62.3KDeryk Jones$56.9KGrant Garcia$55.2KDavid Flanigan$51.7K
  1. 1

    Matthew a Tao

    $68,282.39 across 42 reported transactions

  2. 2

    Michael Kuhn

    $62,250.98 across 30 reported transactions

  3. 3

    Deryk Jones

    $56,852.57 across 35 reported transactions

  4. 4

    Grant Garcia

    $55,194.18 across 40 reported transactions

  5. 5

    David Flanigan

    $51,716.00 across 14 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $402.21. Average per recipient: $405.24.

Total Amount

$1,342,981.04

Avg per Transaction

$402.21

Avg per Recipient

$405.24

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Vericel Corporation Share

0.0%

#548 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Vericel Corporation

Biofrontera Bioscience GmbH

$1.3M 0 recipients

Telix Pharmaceuticals

$1.3M 2,920 recipients

Leadiant Biosciences, Inc.

$1.3M 65 recipients

Surmodics, Inc.

$1.3M 2,433 recipients

C. R. Bard, Inc. & Subsidiaries

$1.3M 2,216 recipients

Trillium Therapeutics USA, LLC

$1.3M 0 recipients

Frequently Asked Questions

How much did Vericel Corporation pay to physicians and hospitals in 2024? ▾
In Program Year 2024, CMS Open Payments recorded $1,342,981.04 from Vericel Corporation to physicians and hospitals across 3,339 transactions - 0.0% of all industry payments reported that year.
How many physicians received payments from Vericel Corporation? ▾
Vericel Corporation made payments to 3,314 physicians and teaching hospitals in 2024. The average payment per recipient was $405.24.
What types of payments did Vericel Corporation make? ▾
8 categories of general payment make up Vericel Corporation's reported activity, including consulting, meals, travel, and similar types. The largest general-payment category was "Consulting Fee" at $530.3K, representing 39.5% of the company's reported total.
How does Vericel Corporation rank among pharmaceutical companies? ▾
By total payment amount, Vericel Corporation sits at #548 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from Vericel Corporation? ▾
Vericel Corporation's 3,339 transactions to 3,314 recipients in 2024 averaged $402.21 per transaction.
Where does the payment data for Vericel Corporation come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Vericel Corporation's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.